$58.51
1.021.77%
Last update: Oct 30, 5:25 PM
BioMarin Pharmaceutical Inc (BMRN) Stock Price, Quote, News & History
BMRNNASDAQ
Martin Shkreli calls Ultragenyx undervalued and a takeover target as the stock tanks after a trial failure.
You can purchase shares of BioMarin Pharmaceutical (NASDAQ:BMRN) through any online brokerage.
Other companies in BioMarin Pharmaceutical’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
BioMarin Pharmaceutical has a consensus price target of $88.76.
The stock price for BioMarin Pharmaceutical (NASDAQ: BMRN) is $58.5569 last updated October 30, 2026 at 5:25 PM EDT.
There are no upcoming dividends for BioMarin Pharmaceutical.
BioMarin Pharmaceutical does not have any upcoming earnings scheduled.
There is no upcoming split for BioMarin Pharmaceutical.
BioMarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex...
